N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid
C58H77Cl2F3N14O12S2 — CID 157427964
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid
N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid (PubChem CID 157427964) has the molecular formula C58H77Cl2F3N14O12S2 and a molecular weight of 1354.37 g/mol. Its IUPAC name is N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 157427964 |
| Molecular Formula | C58H77Cl2F3N14O12S2 |
| Molecular Weight | 1354.37 g/mol |
| Exact Mass | 1352.46 |
| IUPAC Name | N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid |
| SMILES | C.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](N)C[C@H]1CO.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](NC(=O)OC(C)(C)C)C[C@H]1CO.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C30H40ClN7O6S.C25H32ClN7O4S.C2HF3O2.CH4/c1-18-15-38-26(33-27(18)37-16-20(13-21(37)17-39)32-29(41)44-30(2,3)4)14-24(34-38)25-8-6-7-11-36(25)28(40)22-12-19(31)9-10-23(22)35-45(5,42)43;1-15-12-33-23(28-24(15)32-13-17(27)10-18(32)14-34)11-21(29-33)22-5-3-4-8-31(22)25(35)19-9-16(26)6-7-20(19)30-38(2,36)37;3-2(4,5)1(6)7;/h9-10,12,14-15,20-21,25,35,39H,6-8,11,13,16-17H2,1-5H3,(H,32,41);6-7,9,11-12,17-18,22,30,34H,3-5,8,10,13-14,27H2,1-2H3;(H,6,7);1H4/t20-,21-,25-;17-,18-,22-;;/m00../s1 |
| InChIKey | XZGPUPNEELNTEG-MVYDLPHFSA-N |
| XLogP | 7.49 |
| TPSA | 341.93 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 91 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1354.37 |
| LogP ≤ 5 | 7.49 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157427964 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.